Madison Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Madison Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,826	Closed	-$4.05M	–	308
2022 Q4	$4.05M	Sell	30,826 -5,293	-15%	-$684K	0.06%	186
2022 Q3	$4.22M	Sell	36,119 -22,716	-39%	-$2.82M	0.07%	171
2022 Q2	$6.92M	Buy	58,835 +9,770	+20%	+$1.16M	0.11%	142
2022 Q1	$6.39M	Buy	49,065 +6,891	+16%	+$898K	0.09%	142
2021 Q4	$6.44M	Sell	42,174 -16,725	-28%	-$2.59M	0.08%	156
2021 Q3	$9.52M	Sell	58,899 -5,161	-8%	-$869K	0.13%	129
2021 Q2	$10.5M	Sell	64,060 -5,915	-8%	-$911K	0.14%	129
2021 Q1	$10.5M	Sell	69,975 -46,118	-40%	-$7.33M	0.15%	128
2020 Q4	$17.6M	Buy	116,093 +75,702	+187%	+$10.8M	0.26%	105
2020 Q3	$5.47M	Sell	40,391 -33,315	-45%	-$4.52M	0.09%	150
2020 Q2	$10.1M	Buy	73,706 +5,421	+8%	+$691K	0.18%	113
2020 Q1	$7.36M	Buy	68,285 +13,535	+25%	+$1.56M	0.15%	117
2019 Q4	$6.6M	Buy	+54,750	New	+$6.11M	0.1%	162

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Madison Asset Management's IBB Position: Q1 2023 in Review

Madison Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 30,826 shares — an estimated $4.05M sold.

Madison Asset Management first reported a position in IBB in Q4 2019 and held it in 13 quarters. The position peaked at $17.6M in Q4 2020. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Madison Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Madison Asset Management sold 30,826 iShares Biotechnology ETF shares in Q1 2023, an estimated $4.05M.
Madison Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 13 quarters.
Madison Asset Management's iShares Biotechnology ETF position peaked at $17.6M in Q4 2020.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Madison Asset Management's 13F filing for Q1 2023, filed 26 Apr 2023.